26.02.2020
- Together for Sustainability (TFS), a global, procurement-driven chemical industry initiative emphasizing sustainable supply chains, has further increased its impact by adding...
25.02.2020
- French drugmaker Sanofi plans to establish a new major active pharmaceutical ingredients company that it says would secure significant manufacturing and supply capacities that are...
19.02.2020
- Sanofi Pasteur, the vaccines global business unit of French drugmaker Sanofi, plans to work with the Biomedical Advanced Research and Development Authority (BARDA), part of the US...
13.02.2020
- Paul Hudson, new CEO of Sanofi, has taken quick steps to implement a plan announced on Feb. 6 to reduce the company's executive committee from 14 to 10 members. At the company’s Q4...
27.01.2020
- Sanofi has completed its acquisition of US biotech Synthorx as planned for $68 per share in cash. This follows expiration of the French pharma giant’s tender offer for all of the...
10.12.2019
- French drugmaker Sanofi has signed a definitive agreement to buy Synthorx, a US clinical-stage US biotech focused on cancer and autoimmune disorders, for $68 per share. The cash...
07.11.2019
- French drugmaker Sanofi has paid $315 million to investors to settle claims it dragged its feet on advancing the development of multiple sclerosis drug Lemtrada, which it acquired...
19.09.2019
- French drugmaker Sanofi and US pharma and medical devices company Abbott Laboratories have teamed up to integrate glucose sensing and insulin delivery technologies, with the aim of...
